- Home
- DJTWW vs OGN Comparison
DJTWW vs OGN Comparison
Compare DJTWW & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DJTWW
- OGN
- Stock Information
- Founded
- DJTWW 2021
- OGN 1923
- Country
- DJTWW United States
- OGN United States
- Employees
- DJTWW 29
- OGN N/A
- Industry
- DJTWW Computer Software: Programming Data Processing
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- DJTWW Technology
- OGN Health Care
- Exchange
- DJTWW Nasdaq
- OGN Nasdaq
- Market Cap
- DJTWW 2.5B
- OGN 2.7B
- IPO Year
- DJTWW N/A
- OGN N/A
- Fundamental
- Price
- DJTWW $6.86
- OGN $9.21
- Analyst Decision
- DJTWW
- OGN Buy
- Analyst Count
- DJTWW 0
- OGN 3
- Target Price
- DJTWW N/A
- OGN $17.33
- AVG Volume (30 Days)
- DJTWW 172.0K
- OGN 3.5M
- Earning Date
- DJTWW 04-02-2025
- OGN 10-30-2025
- Dividend Yield
- DJTWW N/A
- OGN 0.87%
- EPS Growth
- DJTWW N/A
- OGN N/A
- EPS
- DJTWW N/A
- OGN 2.69
- Revenue
- DJTWW $3,369,800.00
- OGN $6,281,000,000.00
- Revenue This Year
- DJTWW N/A
- OGN N/A
- Revenue Next Year
- DJTWW N/A
- OGN $0.79
- P/E Ratio
- DJTWW N/A
- OGN $3.41
- Revenue Growth
- DJTWW N/A
- OGN N/A
- 52 Week Low
- DJTWW $6.53
- OGN $8.01
- 52 Week High
- DJTWW $44.83
- OGN $19.05
- Technical
- Relative Strength Index (RSI)
- DJTWW 24.76
- OGN 38.05
- Support Level
- DJTWW $6.88
- OGN $8.87
- Resistance Level
- DJTWW $7.20
- OGN $9.72
- Average True Range (ATR)
- DJTWW 0.41
- OGN 0.31
- MACD
- DJTWW -0.00
- OGN -0.11
- Stochastic Oscillator
- DJTWW 7.06
- OGN 17.62
About DJTWW Trump Media & Technology Group Corp.
Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.